Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Harvard Business School
Moodys
Chubb
UBS
Express Scripts
US Army
Accenture
Chinese Patent Office

Generated: January 22, 2019

DrugPatentWatch Database Preview

Hospira Inc Company Profile

« Back to Dashboard

What is the competitive landscape for HOSPIRA INC, and what generic and branded alternatives to HOSPIRA INC drugs are available?

HOSPIRA INC has eighty-five approved drugs.

There are four tentative approvals on HOSPIRA INC drugs.

Summary for Hospira Inc

Drugs and US Patents for Hospira Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019211-005 Dec 14, 1984 DISCN No No ➤ Sign Up ➤ Sign Up
Hospira Inc ZOLEDRONIC ACID zoledronic acid INJECTABLE;IV (INFUSION) 202837-001 Apr 5, 2013 AP RX No No ➤ Sign Up ➤ Sign Up
Hospira Inc CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 203236-002 Mar 30, 2018 DISCN No No ➤ Sign Up ➤ Sign Up
Hospira Inc HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 090571-003 Aug 31, 2009 AP RX No No ➤ Sign Up ➤ Sign Up
Hospira Inc ZOLEDRONIC ACID zoledronic acid INJECTABLE;IV (INFUSION) 090621-001 Mar 19, 2015 AP RX No No ➤ Sign Up ➤ Sign Up
Hospira Inc ADENOSINE adenosine SOLUTION;INTRAVENOUS 203883-001 Mar 24, 2014 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Hospira Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hospira Inc NIPENT pentostatin INJECTABLE;INJECTION 020122-001 Oct 11, 1991 3,923,785 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for HOSPIRA INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 2007-09-24
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 2011-12-16
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Queensland Health
QuintilesIMS
McKinsey
UBS
Cipla
AstraZeneca
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.